|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.08 USD | +0.92% |
|
-3.54% | -2.46% |
| 12:50pm | Jefferies Adjusts MetLife Price Target to $96 From $101, Maintains Buy Rating | MT |
| 02-07 | MetLife, Inc., Q4 2025 Pre Recorded Earnings Call, Feb 04, 2026 |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.64 | 0.73 | 0.33 | 0.2 | 0.51 | |||||
Return on Total Capital | 2.81 | 3.14 | 1.55 | 1.47 | 3.67 | |||||
Return On Equity % | 7.67 | 9.22 | 5.38 | 5.31 | 15.34 | |||||
Return on Common Equity | 7.38 | 8.95 | 4.98 | 4.61 | 14.71 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 29.59 | 29.14 | 21.31 | 20.74 | 24.69 | |||||
SG&A Margin | - | - | - | - | - | |||||
EBITDA Margin % | 12.16 | 13.37 | 6.03 | 4.37 | 8.82 | |||||
EBITA Margin % | 11.55 | 12.72 | 5.43 | 3.3 | 7.81 | |||||
EBIT Margin % | 11.55 | 12.72 | 5.43 | 3.3 | 7.81 | |||||
Income From Continuing Operations Margin % | 7.99 | 9.25 | 3.66 | 2.39 | 6.26 | |||||
Net Income Margin % | 7.97 | 9.22 | 3.63 | 2.36 | 6.24 | |||||
Net Avail. For Common Margin % | 7.65 | 8.94 | 3.37 | 2.06 | 5.95 | |||||
Normalized Net Income Margin | 6.37 | 7.12 | 2.53 | 1.98 | 4.92 | |||||
Levered Free Cash Flow Margin | 6.14 | 8.55 | 3.54 | -12.06 | 4.05 | |||||
Unlevered Free Cash Flow Margin | 6.98 | 9.36 | 4.38 | -11.09 | 4.97 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.09 | 0.09 | 0.1 | 0.1 | 0.1 | |||||
Fixed Assets Turnover | 25.12 | 29.47 | 34.34 | 19.05 | 20.03 | |||||
Receivables Turnover (Average Receivables) | 3.33 | 3.67 | 4.05 | 2.99 | 2.39 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.07 | 1.03 | 1.21 | 1.54 | 1.54 | |||||
Quick Ratio | 0.82 | 0.8 | 0.97 | 1.3 | 1.28 | |||||
Operating Cash Flow to Current Liabilities | 0.19 | 0.19 | 0.27 | 0.29 | 0.31 | |||||
Days Sales Outstanding (Average Receivables) | 109.8 | 99.35 | 90.08 | 122.03 | 153.44 | |||||
Average Days Payable Outstanding | 168.82 | 160.59 | 142.58 | 117.39 | 116.83 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 145.39 | 161.02 | 373.94 | 219.5 | 233.41 | |||||
Total Debt / Total Capital | 59.25 | 61.69 | 78.9 | 68.7 | 70.01 | |||||
LT Debt/Equity | 104.77 | 112.62 | 282.64 | 150.5 | 156.57 | |||||
Long-Term Debt / Total Capital | 42.7 | 43.15 | 59.64 | 47.11 | 46.96 | |||||
Total Liabilities / Total Assets | 90.59 | 91.08 | 95.91 | 95.6 | 95.91 | |||||
EBIT / Interest Expense | 8.58 | 9.83 | 4.05 | 2.11 | 5.35 | |||||
EBITDA / Interest Expense | 9.28 | 10.55 | 4.7 | 2.99 | 6.22 | |||||
(EBITDA - Capex) / Interest Expense | 9.28 | 10.55 | 4.7 | 2.99 | 6.22 | |||||
Total Debt / EBITDA | 12.83 | 11.24 | 23.16 | 21.24 | 10.03 | |||||
Net Debt / EBITDA | 10.5 | 9.17 | 18.58 | 14.64 | 6.91 | |||||
Total Debt / (EBITDA - Capex) | 12.83 | 11.24 | 23.16 | 21.24 | 10.03 | |||||
Net Debt / (EBITDA - Capex) | 10.5 | 9.17 | 18.58 | 14.64 | 6.91 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -2.55 | 4.77 | -1.66 | -2.71 | 6.1 | |||||
Gross Profit, 1 Yr. Growth % | -1.99 | 3.16 | -28.09 | -4.6 | 26.32 | |||||
EBITDA, 1 Yr. Growth % | 0.32 | 15.2 | -55.63 | -31.88 | 113.98 | |||||
EBITA, 1 Yr. Growth % | -0.23 | 15.39 | -58.03 | -39.05 | 151.25 | |||||
EBIT, 1 Yr. Growth % | -0.23 | 15.39 | -58.03 | -39.05 | 151.25 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -8.31 | 21.35 | -61.1 | -69.78 | 177.4 | |||||
Net Income, 1 Yr. Growth % | -8.34 | 21.21 | -61.26 | -70.14 | 180.48 | |||||
Normalized Net Income, 1 Yr. Growth % | 0.33 | 17.12 | -65.05 | -66.48 | 163.38 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -6.27 | 28.7 | -60.19 | -71.27 | 228.18 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -6.24 | -15.46 | -15.79 | 2.89 | -0.93 | |||||
Accounts Receivable, 1 Yr. Growth % | -12.6 | -3.95 | 1.88 | 66.85 | 2.73 | |||||
Total Assets, 1 Yr. Growth % | 7.38 | -4.46 | -12.25 | 3.7 | -1.47 | |||||
Common Equity, 1 Yr. Growth % | 12.72 | -9.49 | -59.93 | 0.45 | -8.56 | |||||
Tangible Book Value, 1 Yr. Growth % | 11.77 | -10.41 | -72.58 | 1.41 | -10.76 | |||||
Cash From Operations, 1 Yr. Growth % | -15.57 | 8.22 | 4.83 | 5.19 | 6.39 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -32.47 | 45.89 | -59.29 | -671.56 | -135.51 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -30 | 40.46 | -53.99 | -471.18 | -147.33 | |||||
Dividend Per Share, 1 Yr. Growth % | 4.6 | 4.4 | 4.21 | 4.04 | 4.61 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -0.07 | 1.04 | 1.5 | -1.31 | 1.6 | |||||
Gross Profit, 2 Yr. CAGR % | 0.14 | 0.56 | -13.87 | -15.19 | 9.78 | |||||
EBITDA, 2 Yr. CAGR % | 2.57 | 7.5 | -28.51 | -42.62 | 20.73 | |||||
EBITA, 2 Yr. CAGR % | 2.3 | 7.3 | -30.41 | -48.09 | 23.75 | |||||
EBIT, 2 Yr. CAGR % | 2.3 | 7.3 | -30.41 | -48.09 | 23.75 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 2.79 | 5.48 | -31.29 | -51.73 | -8.45 | |||||
Net Income, 2 Yr. CAGR % | 2.73 | 5.41 | -31.47 | -52.02 | -8.48 | |||||
Normalized Net Income, 2 Yr. CAGR % | 4.21 | 8.4 | -36.02 | -49.97 | -6.04 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 7.56 | 9.83 | -28.42 | -51.36 | -2.9 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 36.64 | -10.97 | -15.62 | 26.94 | 0.96 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.6 | -8.38 | -1.08 | 30.12 | 30.92 | |||||
Total Assets, 2 Yr. CAGR % | 7.54 | 1.29 | -8.44 | -4.87 | 1.08 | |||||
Common Equity, 2 Yr. CAGR % | 18.9 | 1.01 | -39.78 | -33.31 | -4.16 | |||||
Tangible Book Value, 2 Yr. CAGR % | 21.59 | 0.07 | -50.44 | -40.09 | -4.87 | |||||
Cash From Operations, 2 Yr. CAGR % | -0.42 | -4.41 | 6.51 | 5.42 | 5.79 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 31.96 | -0.75 | -22.93 | 20.62 | 42.74 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 23.74 | -0.84 | -19.61 | 10.07 | 32.81 | |||||
Dividend Per Share, 2 Yr. CAGR % | 4.71 | 4.5 | 4.3 | 4.13 | 4.33 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 2.88 | 1.52 | 0.13 | -0.46 | 1.1 | |||||
Gross Profit, 3 Yr. CAGR % | 5.38 | 1.14 | -10.08 | -11.59 | -3.15 | |||||
EBITDA, 3 Yr. CAGR % | 15.29 | 6.62 | -19.96 | -29.22 | -11.02 | |||||
EBITA, 3 Yr. CAGR % | 17.45 | 6.49 | -21.53 | -34.46 | -12.19 | |||||
EBIT, 3 Yr. CAGR % | 17.45 | 6.49 | -21.53 | -34.46 | -12.19 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 2.67 | 8.64 | -24.35 | -33.38 | -13.54 | |||||
Net Income, 3 Yr. CAGR % | 10.48 | 8.56 | -24.5 | -33.67 | -13.57 | |||||
Normalized Net Income, 3 Yr. CAGR % | 23.2 | 8.35 | -25.67 | -32.51 | -12.97 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 7.83 | 14.19 | -21.69 | -31.7 | -8.09 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 23.14 | 16.44 | -12.61 | 10.86 | 16.87 | |||||
Accounts Receivable, 3 Yr. CAGR % | -0.85 | -4.38 | -5.08 | 17.6 | 20.26 | |||||
Total Assets, 3 Yr. CAGR % | 3.37 | 3.38 | -3.44 | -4.73 | -3.75 | |||||
Common Equity, 3 Yr. CAGR % | 8.31 | 8.56 | -25.78 | -26.16 | -25.91 | |||||
Tangible Book Value, 3 Yr. CAGR % | 9.12 | 9.82 | -35 | -31.49 | -31.58 | |||||
Cash From Operations, 3 Yr. CAGR % | -1.78 | 2.38 | -1.43 | 5.64 | 5.74 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 0.38 | 36.45 | -26.25 | 24.64 | -19.66 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -0.61 | 29.08 | -23.24 | 16.11 | -16.81 | |||||
Dividend Per Share, 3 Yr. CAGR % | 4.39 | 4.6 | 4.4 | 4.22 | 4.29 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 2.06 | 3.2 | 2.33 | -0.31 | 0.39 | |||||
Gross Profit, 5 Yr. CAGR % | -0.26 | 2.88 | -2.79 | -7.07 | -3.07 | |||||
EBITDA, 5 Yr. CAGR % | 2.54 | 9.37 | -4.77 | -17.9 | -5.31 | |||||
EBITA, 5 Yr. CAGR % | 2.89 | 9.95 | -4.74 | -21.68 | -6.73 | |||||
EBIT, 5 Yr. CAGR % | 2.89 | 9.95 | -4.74 | -21.68 | -6.73 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 5.94 | 12.88 | -12.57 | -20.76 | -5.54 | |||||
Net Income, 5 Yr. CAGR % | 0.13 | 50.46 | -8.74 | -20.98 | -5.58 | |||||
Normalized Net Income, 5 Yr. CAGR % | 3.94 | 12.34 | -5.2 | -19.7 | -4.08 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 10.55 | 18.49 | -8.47 | -18.09 | -0.4 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 23.77 | 11.2 | 5.86 | 20.53 | 4.82 | |||||
Accounts Receivable, 5 Yr. CAGR % | -4.43 | 2.26 | -0.94 | 8.16 | 7.86 | |||||
Total Assets, 5 Yr. CAGR % | -1.96 | -3.31 | -1.53 | 0 | -1.76 | |||||
Common Equity, 5 Yr. CAGR % | 1.87 | -0.01 | -14.35 | -10.66 | -16.13 | |||||
Tangible Book Value, 5 Yr. CAGR % | 1.73 | -0.5 | -20.42 | -13.82 | -20.34 | |||||
Cash From Operations, 5 Yr. CAGR % | -3.7 | -3.14 | 1.46 | 3.17 | 1.15 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 19.01 | -22.47 | -9.69 | 27.52 | -14.16 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 14.37 | -21.55 | -8.7 | 19.1 | -12.23 | |||||
Dividend Per Share, 5 Yr. CAGR % | 4.29 | 3.82 | 4.35 | 4.41 | 4.37 |
- Stock Market
- Equities
- MET Stock
- Financials MetLife, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















